Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by DeathXray33


V.TLT

RE:RE:Quote from Keytruda.com

skys1 wrote: So Gman, you think Keytruda is the "exact sweet spot"?...

January 25, 2024

V.TLT

RE:FDA Pre-Breakthrough Therapy Designation Advice

Eoganacht wrote: I found some interesting infornation online about pre-BTD...

January 24, 2024

V.TLT

RE:Licensing Deal

enriquesuave wrote: Nanobiotix signed a deal with Janssen in June. $30...

January 23, 2024

V.TLT

RE:Is a 25% No Response rate inevitable ?

Eoganacht wrote: Our current trial results are excellent and should get us...

January 23, 2024

V.TLT

RE:RE:RE:RE:BTD is slow process.

Eoganacht wrote: By the way, if the FDA suggested Theralase submit the 18...

January 19, 2024

V.TLT

RE:RE:RE:RE:RE:BTD is slow process.

stocksnbonds458 wrote: Agreed patience. From what I understand it's just...

January 17, 2024

V.TLT

RE:RE:RE:RE:Dr. Ashish Kamat Interview - BOND-003 Study Results

Eoganacht wrote: Ruvidar PDT is far superior in number of treatments and I...

January 9, 2024

V.TLT

RE:RE:RE:Roger Video Hot Off The Press ! 3 Hours Old !

Longholder99 wrote: Efficacy and safety superior to currently FDA approved...

January 9, 2024

V.TLT

RE:RE:RE:Email from Matthew Perraton

"Theralase intends to commence a Phase Ia/Ib dose escalating clinical...

January 7, 2024

V.TLT

RE:TAR-200 and other

DJDawg wrote: The TAR-200 monotherapy works as you would expect. The...

January 5, 2024

V.TLT

RE:RE:Big Breakthrough In Cancer Treatment: Scientists Destroy 99%

riverrrow wrote: A test tube full of cancer cells doesn't tell you how...

December 30, 2023

V.TLT

RE:RE:RE:RE:RE:Only 11 patients were enrolled in 2023….

Kayz88 wrote: https://www.dana-farber.org/clinical-trials/21-224 My...

December 24, 2023

V.TLT

RE:RE:I know a sale when i see one :-) Keep the faith

Longholder99 wrote: The value of the patent Theralase holds on Ruthenium and...

December 18, 2023

V.TLT

RE:CG0070 + Pembrolizumab...Not even close to TLT-Ruvidar.

wildbird1 wrote: I am still on my holiday break, but could not resist to give...

December 14, 2023

V.TLT

RE:RE:RE:An example of deceptive headlines for Adstiladrin

StevenBirch wrote: Well let's hope the FDA sees through deceptive...

December 10, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:28 places in this most recent private placement

Oilminerdeluxe wrote: That fast AA.approval we hope for. Wasn't it said...

December 8, 2023

V.TLT

RE:RE:RE:Did the FDA Move the BTD Goal Posts?

Rumpl3StiltSkin wrote: Haven't we already established that these other...

December 5, 2023

V.TLT

RE:RE:RE:RE:RE:Groundhog Quarter

StevenBirch wrote: My two takeaways are the numbers are really good vs the...

December 1, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:1St quarter BTD

enriquesuave wrote: Data is definitely looking better and better!  ...

November 30, 2023

V.TLT

RE:RE:RE:RE:RE:The market is so smart

TriumphSpitSix wrote: Nice trade. Some boiler room shlub will be along any...

November 26, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 Next

Featured Company